[Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage*; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage*; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Traitement de 100 tuberculeux pulmonaires dont les bacilles sont résistants à la streptomycine, l'isoniazide et l'éthionamide, par une association de rifampicine et d'éthambutol. Comparaison entre deux dosages de rifampicine (traitement quotidien pendant 4 mois, bihebdomadaire les 8 mois suivants)